(RF) Eurazeo - Ratings and Ratios
Investments, RealEstate, ConsumerBrands, Healthcare, Technology
RF EPS (Earnings per Share)
RF Revenue
Description: RF Eurazeo
Eurazeo SE is a private equity and venture capital firm that specializes in various investment strategies, including growth capital, acquisitions, and leveraged buyouts, targeting private and public companies across different sectors and geographies.
The firms investment focus is on medium-sized to large companies, SMEs, and high-growth businesses, with a particular emphasis on sectors driven by digital transformation and changes in lifestyle and consumption, such as smart cities, fintech, luxury, and healthcare. Eurazeo also invests in real estate management and development projects, particularly in Western Europe.
From a performance perspective, Eurazeos Return on Equity (RoE) stands at 17.89%, indicating a relatively strong ability to generate profits from shareholder equity. With a market capitalization of approximately €4.5 billion, Eurazeo is a significant player in the European private equity and venture capital landscape.
In terms of investment size, Eurazeo typically invests between €50 million to €250 million in small to mid-buyout businesses, €25 million to €100 million in growth businesses, and €10 million to €40 million in other opportunities. The firms investment activities are diversified across various regions, including Europe, North America, and China.
To evaluate Eurazeos performance, key performance indicators (KPIs) such as Assets Under Management (AUM) growth, investment portfolio return, and dividend yield can be considered. Additionally, metrics like the firms internal rate of return (IRR) and cash-on-cash return can provide insights into its investment performance.
Additional Sources for RF Stock
RF Stock Overview
| Market Cap in USD | 4,740m |
| Sector | Financial Services |
| Industry | Asset Management |
| GiC Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception |
RF Stock Ratings
| Growth Rating | 13.2 |
| Fundamental | 28.1 |
| Dividend Rating | 75.4 |
| Rel. Strength | -39.6 |
| Analysts | - |
| Fair Price Momentum | 41.92 EUR |
| Fair Price DCF | - |
RF Dividends
| Dividend Yield 12m | 4.47% |
| Yield on Cost 5y | 6.91% |
| Annual Growth 5y | 12.70% |
| Payout Consistency | 92.7% |
| Payout Ratio | 8.6% |
RF Growth Ratios
| Growth Correlation 3m | -51.1% |
| Growth Correlation 12m | -52.6% |
| Growth Correlation 5y | 42.8% |
| CAGR 5y | 5.99% |
| CAGR/Max DD 5y | 0.15 |
| Sharpe Ratio 12m | 1.43 |
| Alpha | -35.54 |
| Beta | 0.899 |
| Volatility | 25.83% |
| Current Volume | 108.6k |
| Average Volume 20d | 108.7k |
| Stop Loss | 49.7 (-3.7%) |
As of July 31, 2025, the stock is trading at EUR 51.60 with a total of 108,615 shares traded.
Over the past week, the price has changed by -20.19%, over one month by -14.78%, over three months by -14.52% and over the past year by -26.33%.
Neither. Based on ValueRay´s Fundamental Analyses, Eurazeo is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.07 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RF is around 41.92 EUR . This means that RF is currently overvalued and has a potential downside of -18.76%.
Eurazeo has no consensus analysts rating.
According to our own proprietary Forecast Model, RF Eurazeo will be worth about 50.3 in July 2026. The stock is currently trading at 51.60. This means that the stock has a potential downside of -2.62%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.2 | 59.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 50.3 | -2.6% |